gossypolone has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, F; Lan, B; Li, X; Peng, B; Shi, Z; Wang, X; Zhang, G | 1 |
| Blackstaffe, L; Fish, RG; Shelley, MD | 1 |
2 other study(ies) available for gossypolone and Melanoma
| Article | Year |
|---|---|
Combination therapy with BH3 mimetic and hyperthermia tends to be more effective on anti-melanoma treatment.
Topics: Animals; Apoptosis; BH3 Interacting Domain Death Agonist Protein; Biomimetics; Cell Line, Tumor; Cell Movement; Combined Modality Therapy; Gossypol; Humans; Hyperthermia, Induced; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Male; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microwaves; Signal Transduction; Skin Neoplasms | 2018 |
Cytotoxicity of gossypol enantiomers and its quinone metabolite gossypolone in melanoma cell lines.
Topics: Cell Adhesion; Cell Division; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Gossypol; Humans; Melanoma; Microscopy, Electron, Scanning; Stereoisomerism; Tumor Cells, Cultured | 1997 |